✦ LIBER ✦

Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Endometrial Carcinoma

✍ Scribed by Harry J. Long III; Robert M. Langdon Jr.; Stephen S. Cha; Michael H. Veeder; Delano M. Pfeifle; James E. Krook; Larry P. Ebbert; Loren K. Tschetter; Steven G. Roshon

Book ID: 115616612
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 184 KB
Volume: 58
Category: Article
ISSN: 0090-8258
DOI: 10.1006/gyno.1995.1217

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Methotrexate, Vinblast

Phase II Trial of Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced/Recurrent Carcinoma of the Uterine Cervix and Vagina

✍ Harry J. Long III; William G. Cross; H.S. Wieand; Maurice J. Webb; James A. Mail 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Phase II Trial of Doxorubicin, 5-Fluorou

Phase II Trial of Doxorubicin, 5-Fluorouracil, Etoposide, and Cisplatin in Advanced or Recurrent Endometrial Carcinoma

✍ J-Y. Pierga; V. Diéras; P. Beuzeboc; T. Dorval; T. Palangié; M. Jouve; S.M. Scho 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 50 KB

A phase II trial of neoadjuvant methotre

A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

✍ Louise E. Morrell; Young J. Lee; Judith Hurley; Mayda Arias; Carolyn Mies; Steph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate

A Phase II trial of methotrexate, vinbla

A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix

✍ Christos A. Papadimitriou; Meletios A. Dimopoulos; Nikolaos Giannakoulis; Kyrill 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 3 views

## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign

Phase III comparison of methotrexate, vi

Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium

✍ Harry J. Long III; Robert A. Nelimark; Karl C. Podratz; Vera Suman; Gary L. Keen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Phase II trial of vinblastine in advance

Phase II trial of vinblastine in advanced ovarian carcinoma

✍ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro